Capital Guardian Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | $60.6M | Buy |
1,477,833
+641,888
| +77% | +$26.3M | 0.82% | 43 |
|
2019
Q1 | $35.7M | Sell |
835,945
-923,950
| -53% | -$39.5M | 0.47% | 87 |
|
2018
Q4 | $66.8M | Buy |
1,759,895
+104,256
| +6% | +$3.96M | 1.06% | 28 |
|
2018
Q3 | $65.5M | Buy |
1,655,639
+106,847
| +7% | +$4.23M | 0.88% | 38 |
|
2018
Q2 | $54.4M | Buy |
1,548,792
+115,351
| +8% | +$4.05M | 0.77% | 53 |
|
2018
Q1 | $50.1M | Buy |
1,433,441
+219,059
| +18% | +$7.66M | 0.71% | 59 |
|
2017
Q4 | $42.1M | Buy |
1,214,382
+1,106,862
| +1,029% | +$38.4M | 0.6% | 66 |
|
2017
Q3 | $3.64M | Sell |
107,520
-71,880
| -40% | -$2.44M | 0.06% | 143 |
|
2017
Q2 | $6.12M | Sell |
179,400
-2,944,926
| -94% | -$100M | 0.11% | 134 |
|
2017
Q1 | $97.3M | Buy |
3,124,326
+590,761
| +23% | +$18.4M | 0.73% | 52 |
|
2016
Q4 | $69.2M | Sell |
2,533,565
-153,798
| -6% | -$4.2M | 0.54% | 72 |
|
2016
Q3 | $88.3M | Buy |
2,687,363
+144,543
| +6% | +$4.75M | 0.67% | 56 |
|
2016
Q2 | $76.8M | Buy |
2,542,820
+42,803
| +2% | +$1.29M | 0.59% | 63 |
|
2016
Q1 | $70.4M | Buy |
2,500,017
+311,258
| +14% | +$8.76M | 0.54% | 74 |
|
2015
Q4 | $74.3M | Buy |
2,188,759
+403,952
| +23% | +$13.7M | 0.58% | 60 |
|
2015
Q3 | $56.8M | Buy |
1,784,807
+344,429
| +24% | +$11M | 0.46% | 83 |
|
2015
Q2 | $45.9M | Buy |
1,440,378
+232,108
| +19% | +$7.39M | 0.33% | 105 |
|
2015
Q1 | $41.3M | Buy |
1,208,270
+414,342
| +52% | +$14.2M | 0.31% | 105 |
|
2014
Q4 | $27.9M | Buy |
793,928
+326,812
| +70% | +$11.5M | 0.19% | 121 |
|
2014
Q3 | $16.7M | Buy |
467,116
+464,916
| +21,133% | +$16.6M | 0.12% | 144 |
|
2014
Q2 | $82K | Hold |
2,200
| – | – | ﹤0.01% | 355 |
|
2014
Q1 | $71K | Sell |
2,200
-190
| -8% | -$6.13K | ﹤0.01% | 360 |
|
2013
Q4 | $71K | Buy |
2,390
+190
| +9% | +$5.64K | ﹤0.01% | 351 |
|
2013
Q3 | $57K | Hold |
2,200
| – | – | ﹤0.01% | 334 |
|
2013
Q2 | $52K | Buy |
+2,200
| New | +$52K | ﹤0.01% | 323 |
|